Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) EPS (Weighted Average and Diluted) (2021 - 2023)

Terns Pharmaceuticals (TERN) has disclosed EPS (Weighted Average and Diluted) for 3 consecutive years, with -$0.29 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, EPS (Weighted Average and Diluted) rose 33.73% year-over-year to -$0.29, compared with a TTM value of -$1.27 through Dec 2023, down 190.22%, and an annual FY2023 reading of -$1.27, up 23.95% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.29 for Q4 2023 at Terns Pharmaceuticals, up from -$0.42 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.25 in Q2 2023 and bottomed at -$0.57 in Q4 2021.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$0.45, with a median of -$0.49 recorded in 2021.
  • The sharpest move saw EPS (Weighted Average and Diluted) decreased 4.37% in 2022, then surged 54.57% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.57 in 2021, then grew by 23.23% to -$0.44 in 2022, then surged by 33.73% to -$0.29 in 2023.
  • Business Quant data shows EPS (Weighted Average and Diluted) for TERN at -$0.29 in Q4 2023, -$0.42 in Q3 2023, and -$0.25 in Q2 2023.